Please ensure Javascript is enabled for purposes of website accessibility

GoPath® Diagnostics Launches FDA-Cleared CGP Test under OncoTarget® 500

Share on facebook
Share on twitter
Share on linkedin
#ASCO22 week is here and we are excited to announce the release of our FDA-Cleared CGP Test under OncoTarget® 500. Visit us in booth #28109 on June 4-6 between 9:00 AM–5:00 PM each day and learn how this CGP solution will help advance cancer treatments by identifying genomic targets for both targeted therapy and immunotherapy.